M11.062
Hydroxyapatite deposition disease, left knee
Clinical Classification Guidelines
Medical Intelligence & Overview
Hydroxyapatite deposition disease (HADD) in the left knee is a condition characterized by the accumulation of tiny crystals of hydroxyapatite, a mineral normally found in bones, within the soft tissues around the knee joint. This buildup can lead to inflammation, pain, and limited movement. While it most commonly affects the shoulder, it can also occur in other joints, including the knee. Recognizing and understanding this condition is important for managing symptoms and improving quality of life.
Causes & Symptoms
Clinical Causes: T h e e x a c t c a u s e o f h y d r o x y a p a t i t e c r y s t a l d e p o s i t i o n r e m a i n s u n c l e a r . H o w e v e r , s e v e r a l f a c t o r s m a y c o n t r i b u t e t o i t s d e v e l o p m e n t : - D e g e n e r a t i v e c h a n g e s i n t h e j o i n t t i s s u e s - R e p e t i t i v e t r a u m a o r i n j u r y t o t h e k n e e - A g e - r e l a t e d d e g e n e r a t i o n - M e t a b o l i c a b n o r m a l i t i e s a f f e c t i n g m i n e r a l m e t a b o l i s m - C h r o n i c j o i n t d i s e a s e o r o s t e o a r t h r i t i s - G e n e t i c p r e d i s p o s i t i o n s m i g h t a l s o p l a y a r o l e , t h o u g h f u r t h e r r e s e a r c h i s n e e d e d t o c l a r i f y t h i s .
Key Symptoms: I n d i v i d u a l s w i t h h y d r o x y a p a t i t e d e p o s i t i o n d i s e a s e i n t h e k n e e m a y e x p e r i e n c e a r a n g e o f s y m p t o m s , w h i c h c a n i n c l u d e : - S u d d e n o r g r a d u a l o n s e t o f k n e e p a i n - S w e l l i n g a n d t e n d e r n e s s a r o u n d t h e j o i n t - R e d u c e d r a n g e o f m o t i o n o r s t i f f n e s s - W a r m t h i n t h e a f f e c t e d k n e e - P a i n t h a t w o r s e n s w i t h m o v e m e n t o r a c t i v i t y - P o s s i b l e c l i c k i n g o r c a t c h i n g s e n s a t i o n w h e n m o v i n g t h e k n e e - O c c a s i o n a l l y , t h e r e m i g h t b e r e d n e s s a n d v i s i b l e s w e l l i n g i f i n f l a m m a t i o n i s s i g n i f i c a n t .
Diagnostic & Treatment
Diagnosis Path: To diagnose hydroxyapatite deposition disease, healthcare providers typically perform a combination of evaluations: - Medical history review focusing on symptom onset and any previous joint issues - Physical examination to assess swelling, tenderness, and range of motion - Imaging tests such as X-rays, which can reveal calcifications in the soft tissues around the knee - Ultrasound imaging, which can detect crystals and inflammation - Occasionally, joint aspiration and analysis of synovial fluid may be used to identify hydroxyapatite crystals and exclude other conditions like gout or infection. - MRI scans might be ordered in complex cases to evaluate the extent of tissue involvement and rule out other problems.
Treatment Protocols: Managing hydroxyapatite deposition disease in the knee typically involves measures to reduce inflammation, alleviate pain, and improve joint function: - Rest and activity modification to prevent aggravation - Application of ice packs to reduce swelling and discomfort - Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain relief and inflammation control - Corticosteroid injections directly into the knee joint may be used for significant inflammation - Physical therapy can aid in restoring joint mobility and strength - In some cases, procedures to remove calcifications or irrigation of the joint might be considered - Addressing underlying metabolic or degenerative conditions is essential to prevent recurrence - Surgical intervention is rarely necessary but may be considered in severe or persistent cases where other treatments have failed. It is important to follow a healthcare professional’s guidance for tailored management suited to individual needs.
Clinical Advice & FAQs
Billing Guidance
Is M11.062 a billable ICD-10 code?
Yes, M11.062 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.062?
Clinical documentation must specify the nature of Hydroxyapatite deposition disease, left knee and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
